Metabolon will participate in AD/PD 2023 Advances in Science & Therapy International Conference on Alzheimer’s and Parkinson’s Diseases and related neurological disorders in Gothenburg, Sweden. This hybrid event focuses on basic science and clinical research and aims for a better future for all affected by neurodegenerative diseases.
Search
Recent Posts
- ASHG 2024 Recap
- Unlocking Heart Health: How Metabolomics is Transforming the Early Detection of Myocardial Infarction
- Metabolon Services Used in Pioneering Multiomic Research on Brain Metabolism and Neurodegenerative Disorders
- Metabolon Launches New “Guide to Multiomics” and Accompanying Multiomics Webinar
- Metabolon Expands Integrated Bioinformatics Platform to Include Advanced Statistical Analysis Tool
Recent Comments